Clinical Trials on Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute
Total 7729 results
-
Bristol-Myers SquibbCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Japan
-
Novartis PharmaceuticalsRecruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Puerto Rico, South Africa
-
European Organisation for Research and Treatment...UnknownLeukemiaFrance, Belgium, Netherlands, Italy, Czech Republic, Portugal, Germany, Croatia, Turkey, Austria, Hungary
-
European Organisation for Research and Treatment...UnknownLeukemiaBelgium, France, Netherlands, Portugal, Italy, Croatia, Turkey
-
Fred Hutchinson Cancer CenterCompletedMyelodysplastic Syndrome (MDS) | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic Leukemia | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission | Blasts Under 5 Percent of Bone Marrow...United States
-
CelgeneApproved for marketing
-
Fate TherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia | Hematologic Malignancies | Acute Graft-versus-host DiseaseUnited States
-
Medical College of WisconsinRecruitingLeukemia | Burkitt Lymphoma | Lymphoblastic Lymphoma | Myelodysplasia | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission | Chronic Myelogenous Leukemia - Chronic Phase | Chronic Myelogenous Leukemia, Accelerated Phase | Biphenotypic Acute Leukemia | Burkitt Leukemia | Chronic... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaGermany, Australia, Netherlands, Spain, Korea, Republic of, France, Japan, Italy, Singapore, United States
-
Emory UniversityTerminatedRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Bellicum PharmaceuticalsWithdrawnRecurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Recurrent Acute Lymphoblastic Leukemia | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Myelodysplastic... and other conditionsUnited States
-
Virginia Commonwealth UniversityMassey Cancer CenterCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Recurrent Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Plasma... and other conditionsUnited States
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Myelogenous Leukemia, Chronic | Chronic Myelogenous Leukemia in Blast Crisis | Lymphocytic Leukemia, B Cell, Acute
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Myeloid Leukemia With BCR-ABL1United States
-
CepheidCompletedLeukemia, Myelogenous, ChronicUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated
-
UConn HealthCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Stanford UniversityOrca Biosystems, Inc.RecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Acute Leukemia | Chronic Myelogenous Leukemia | Allogeneic Hematopoietic Cell Transplantation (HCT) | Advanced Hematologic MalignanciesUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Philadelphia Chromosome Negative Chronic Myelogenous... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)Completed
-
Columbia UniversityWithdrawn
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedChronic Myelogenous Leukemia - Chronic PhaseChina
-
M.D. Anderson Cancer CenterSchering-PloughTerminatedLeukemia, Myeloid, Philadelphia-PositiveUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedRelapsed Acute Lymphoblastic Leukemia | Relapsed Acute Myelogenous LeukemiaUnited States
-
Asan Medical CenterTerminatedAcute Myelogenous LeukemiaKorea, Republic of
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | AML | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloproliferative Disorder | ALL | Non-malignant Diseases Requiring Allogeneic HSCTUnited States
-
Novartis PharmaceuticalsTerminatedChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Facet BiotechNational Cancer Institute (NCI)UnknownLeukemiaUnited States, Canada, Netherlands, Belgium, Germany, United Kingdom, France
-
Masonic Cancer Center, University of MinnesotaTerminatedChronic Myelogenous Leukemia | Acute Leukemias | Burkitt's LymphomaUnited States
-
Northside Hospital, Inc.Blood and Marrow Transplant Group of GeorgiaCompletedMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelofibrosis | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | CMMLUnited States
-
Indiana UniversityTerminatedMultiple Myeloma | Myelofibrosis | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | Mantle-Cell Lymphoma | Chronic Myelogenous Leukemia | Lymphoma, Non-Hodgkin's | Myelodysplasia | Hodgkin's DiseaseUnited States
-
University of ChicagoCompletedMyelodysplastic Syndromes | Chronic Lymphocytic Leukemia | Anemia, Aplastic | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloproliferative Disorder | Hodgkin's Disease | Lymphoid Leukemia | Malignant LymphomaUnited States
-
Fred Hutchinson Cancer CenterHighPass Bio, Inc.SuspendedAcute Myeloid Leukemia | Leukemia | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory... and other conditionsUnited States
-
III. Medizinische Klinik MannheimUnknownLeukemiaSwitzerland, Germany, Spain, Poland, Czech Republic
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Andrew RezvaniNational Institutes of Health (NIH); Pharmacyclics LLC.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaTurkey
-
Novartis PharmaceuticalsCompletedMyelogenous Leukemia, ChronicSouth Africa, Italy, Belgium, Japan, Taiwan, Turkey, Canada, Germany, Spain, Egypt, United States, Singapore, Austria, France, Netherlands, Sweden, United Kingdom, Korea, Republic of, Hong Kong, Thailand, Russian Federation, Brazil, Hungar... and more
-
PfizerCompletedChronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaCanada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
-
University of LiverpoolImperial College London; Newcastle University; University of GlasgowUnknownChronic Myeloid LeukaemiaUnited Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Brenda Cooper, MDNational Cancer Institute (NCI)CompletedUntreated Adult Acute Myeloid LeukemiaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Myelogenous LeukemiaUnited States, Canada, Australia